Hoffman D R, El-Choufani S E, Smith M M, de Groot H
Department of Pathology and Laboratory Medicine, Brody School of Medicine at East Carolina University, Greenville 27858, USA.
J Allergy Clin Immunol. 2001 Nov;108(5):855-60. doi: 10.1067/mai.2001.119029.
With the increase in commercial vegetable production in greenhouses, occupational sensitization to bumblebee venom is becoming more common. Studies using sera from subjects thus sensitized allow evaluation of the allergenic specificity of bumblebee sensitization.
The purposes of this study were to determine the degree of species group specificity of bumblebee venom allergens in sera of allergic patients and to investigate the structural basis of this specificity.
Allergens were purified from bumblebee venom, studied serologically by direct binding and inhibition techniques, and characterized by enzyme analysis and amino acid sequencing. Three-dimensional models of the phospholipases were constructed and analyzed.
Bombus terrestris venom contains phospholipase A(2), venom protease, hyaluronidase, and acid phosphatase allergens. The protease and phospholipase A(2) allergens contain IgE-reactive epitopes that are different from those seen in Bombus pennsylvanicus, a North American species. Bumblebee phospholipase A(2) is only 53% identical to honeybee phospholipase A(2). The results of 3-dimensional modeling are consistent with the immunologic observations.
Patients with primary bumblebee sensitization should be diagnosed and treated with venom from the appropriate species group of bumblebees. Bumblebee venom phospholipase A(2) and protease are antigenically distinct from honeybee venom proteins. There are significant species group-specific epitopes on bumblebee venom proteins.
随着温室中商业蔬菜生产的增加,职业性对熊蜂毒液致敏变得越来越普遍。使用由此致敏的受试者血清进行的研究有助于评估熊蜂致敏的变应原特异性。
本研究的目的是确定过敏患者血清中熊蜂毒液变应原的物种组特异性程度,并研究这种特异性的结构基础。
从熊蜂毒液中纯化变应原,通过直接结合和抑制技术进行血清学研究,并通过酶分析和氨基酸测序进行表征。构建并分析了磷脂酶的三维模型。
地熊蜂毒液含有磷脂酶A(2)、毒液蛋白酶、透明质酸酶和酸性磷酸酶变应原。蛋白酶和磷脂酶A(2)变应原含有与北美物种宾夕法尼亚熊蜂中所见不同的IgE反应性表位。熊蜂磷脂酶A(2)与蜜蜂磷脂酶A(2)的同源性仅为53%。三维建模结果与免疫学观察结果一致。
原发性熊蜂致敏患者应以适当物种组的熊蜂毒液进行诊断和治疗。熊蜂毒液磷脂酶A(2)和蛋白酶在抗原性上与蜜蜂毒液蛋白不同。熊蜂毒液蛋白上存在显著的物种组特异性表位。